Hfm Investment Advisors, LLC Alkermes Plc. Transaction History
Hfm Investment Advisors, LLC
- $206 Billion
- Q1 2025
A detailed history of Hfm Investment Advisors, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Hfm Investment Advisors, LLC holds 4 shares of ALKS stock, worth $115. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4Holding current value
$115% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
409Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$844 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$528 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$342 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$232 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$200 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.76B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...